Zoledronic Acid Prevents Bone Resorption Caused by the Combination of Radium-223, Abiraterone Acetate, and Prednisone in an Intratibial Prostate Cancer Mouse Model

SIMPLE SUMMARY: The majority of patients with advanced prostate cancer eventually develop bone metastases. Radium-223 has improved overall survival and relieved symptoms related to bone metastases in patients with metastatic castration-resistant prostate cancer (mCRPC). In a phase 3 trial (ERA 223),...

Descripción completa

Detalles Bibliográficos
Autores principales: Suominen, Mari I., Knuuttila, Matias, Sjöholm, Birgitta, Wilson, Timothy, Alhoniemi, Esa, Mumberg, Dominik, Käkönen, Sanna-Maria, Scholz, Arne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452892/
https://www.ncbi.nlm.nih.gov/pubmed/37627143
http://dx.doi.org/10.3390/cancers15164115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452892/
https://www.ncbi.nlm.nih.gov/pubmed/37627143
http://dx.doi.org/10.3390/cancers15164115

Ejemplares similares